div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k src=https:reader034fdocumentsnetreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k src=https:reader034fdocumentsnetreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k src=https:reader034fdocumentsnetreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k src=https:reader034fdocumentsnetreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k...